| 标题 |
 p95HER2, a truncated form of the HER2 oncoprotein, drives an immunosuppressive program in HER2+ breast cancer that limits trastuzumab deruxtecan efficacy |
| 网址 | |
| DOI | |
| 其它 |
期刊：Nat Cancer 作者：Hu D, Lyu X, Li Z, Ekambaram P, Dongre A, Freeman T, Joy M, Atkinson JM, Brown DD, Cai Z, Carleton NM, Crentsil HE, Little J, Kemp F, Klei LR, Beecher M, Sperinde J, Huang W, Joensuu H, Srinivasan A, Pogue-Geile KL, Wang Y, Feng H, Eli LD, Lalani AS, Zou J, Tseng GC, Bruno TC, Lee AV, Oesterreich S, Wolmark N, Allegra CJ, Jacobs SA, McAllister-Lucas LM, Lucas PC 出版日期：2025-06-27 |
| 求助人 | |
| 下载 | 求助已完成，仅限求助人下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)
Nole
Criminology34
小小牛马
cdercder
张欢馨
Essence
乐空思
Kao
GingerF
东方元语
lucky
ming2026
sanvva
OK
luang
一介书生
赵赶超
vampv
dde
初景
皖公网安备34019202002308
